Liquidia (NASDAQ:LQDA) Insider Jason Adair Sells 73,631 Shares of Stock

Liquidia Corporation (NASDAQ:LQDA) insider Jason Adair sold 73,631 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $69.09, for a total value of $5,087,165.79. Following the completion of the transaction, the insider directly owned 174,606 shares in the company, valued at $12,063,528.54. This trade represents a 29.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Adair also recently made the following trade(s):

• On Monday, July 27th, Jason Adair sold 688 shares of Liquidia stock. The stock was sold at an average price of $87.53, for a total value of $60,220.64.
• On Monday, July 13th, Jason Adair sold 7,863 shares of Liquidia stock. The shares were sold at an average price of $71.51, for a total value of $562,283.13.

Liquidia Stock Up 0.3%

Shares of NASDAQ:LQDA traded up $0.22 during mid-day trading on Tuesday, hitting $70.49. 931,033 shares of the company traded hands, compared to its average volume of 1,784,144. The firm’s 50 day simple moving average is $79.26 and its 200 day simple moving average is $56.47. The firm has a market cap of $6.31 billion, a P/E ratio of 51.45 and a beta of 0.58. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31. Liquidia Corporation has a 52-week low of $21.15 and a 52-week high of $93.61.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a return on equity of 149.65% and a net margin of 30.74%.The company had revenue of $171.68 million during the quarter, compared to analysts’ expectations of $168.48 million. During the same quarter in the prior year, the company earned ($0.49) EPS. The firm’s revenue was up 1842.1% compared to the same quarter last year. On average, equities analysts anticipate that Liquidia Corporation will post 2.57 EPS for the current year.

Institutional Trading of Liquidia

Several hedge funds and other institutional investors have recently bought and sold shares of LQDA. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Liquidia in the 4th quarter worth approximately $25,000. Covestor Ltd lifted its stake in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after purchasing an additional 359 shares during the last quarter. NewEdge Advisors LLC bought a new position in Liquidia during the second quarter worth $25,000. Globeflex Capital L P acquired a new position in Liquidia in the second quarter worth $175,000. Finally, Nykredit A S acquired a new position in Liquidia in the second quarter worth $177,000. 64.54% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on LQDA shares. Needham & Company LLC upped their price objective on shares of Liquidia from $70.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Zacks Research lowered Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 13th. Wells Fargo & Company boosted their price target on Liquidia from $62.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price target on shares of Liquidia in a report on Monday, May 11th. Finally, Wall Street Zen downgraded Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $98.08.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).